US Patent 7556930 CD39L3 and its role in diabetes
Patent 7556930 was granted and assigned to Metabolex on July, 2009 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 10, 2006
0
Date of Patent
July 7, 2009
0
Patent Application Number
11402142
0
Patent Inventor Names
Maria E. Wilson
0
Yuko Terasawa
0
Jeffrey D. Johnson
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7556930 CD39L3 and its role in diabetes
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.